GeoVax Awarded $658,000 NIH Grant for its HIV Vaccine Program
ATLANTA, GA--(Marketwired - Apr 3, 2017) - GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today it has received a Notice of Award from the National Institute of Allergy and Infectious Disease (NIAID), part of …